East

By clicking 'Agree' at the bottom of this page you are confirming that you are an Australian wholesale client for the purposes of section 761G of the Corporations Act 2001. 
 
Access to this information is provided on the condition that it is not passed on to any person who is a retail client within the meaning of Section 761G of the Corporations Act 2001. The information contained on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation, or which would subject East Rocky to any registration or other requirement within such jurisdiction or country.

Jurisdiction / Wholesale Investor

About East Rocky

East Rocky Health Sciences Strategy

Performance

All performance figures are quoted net of fees.
Past performance is not indicative of future returns. Returns are based on East Rocky Capital LP, which commenced operations on 31 July 2022.
The benchmark comprises 50% SPDR S&amp;P Biotech ETF (XBI) and 50% iShares Biotechnology ETF (IBB), rebalanced monthly and calculated on a total return basis in US dollars.

East Rocky Health Sciences Strategy (net of fees)

All performance numbers are quoted net of fees